Activation-dependent modulation of B lymphocyte migration to chemokines

Int Immunol. 2000 Sep;12(9):1285-92. doi: 10.1093/intimm/12.9.1285.

Abstract

In this study we have examined the migration responses of human peripheral blood or tonsillar B lymphocytes to a selection of 27 chemokines. Freshly isolated (CD19(+)) B lymphocytes show greatly impaired in vitro chemotaxis which is overcome by overnight culture. The best responses of cultured B lymphocytes were observed with BCA-1, SLC, ELC and SDF-1, reaching 19-26% of total input cells that have migrated, followed by LARC and TECK with 5-10% of migrated cells, whereas no other chemokine was found to be active. Stimulation of B lymphocytes with lipopolysaccharide or anti-CD40 plus IL-4 resulted in marked enhancement of the migration response to BCA-1, SLC, ELC and SDF-1, reaching 30-60% migrated cells at 12 or 36 h of culture respectively. The activation-dependent increase in the migration efficacy was transient and declined to base level responses after 72 h of culture. Under no circumstances did we detect B lymphocyte chemotaxis to inflammatory chemokines. Also, mobilization of intracellular calcium ([Ca(2+)](i)), an otherwise typical response of leukocytes to chemokines, was not observed. The transient increase in B lymphocyte migration did not correlate with changes in chemokine receptor expression, as evidenced by cell surface staining with antibodies to CXCR4, CXCR5 and CCR6, and by receptor transcript analyses. BCA-1, SLC, ELC and SDF-1 are typical 'housekeeping' chemokines with prominent expression at discrete locations in lymphoid tissues. Modulation of migration to these chemokines may be a critical mechanism for the proper positioning of B lymphocytes during humoral responses in secondary lymphoid tissues.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD19 / analysis
  • B-Lymphocytes / drug effects*
  • B-Lymphocytes / immunology
  • CD40 Antigens / immunology
  • Cells, Cultured
  • Chemokine CCL19
  • Chemokine CCL20
  • Chemokine CCL21
  • Chemokine CXCL12
  • Chemokines / pharmacology*
  • Chemokines, CC / pharmacology
  • Chemokines, CXC / pharmacology
  • Chemotaxis, Leukocyte / drug effects*
  • Electrophoresis, Polyacrylamide Gel
  • Ethylenediamines / pharmacology
  • Flow Cytometry
  • Humans
  • Interleukin-4 / pharmacology
  • Leukocytes, Mononuclear / immunology
  • Lipopolysaccharides
  • Macrophage Inflammatory Proteins*
  • Morpholines / pharmacology
  • Palatine Tonsil / immunology
  • RNA / analysis
  • Receptors, CCR6
  • Receptors, CXCR4 / analysis
  • Receptors, CXCR5
  • Receptors, Chemokine / analysis
  • Receptors, Chemokine / genetics
  • Receptors, Cytokine / analysis
  • Time Factors

Substances

  • 4-(3,5-dimethyl-3-aza-5-mercaptohexyl)-6,6-dimethyl-2-thiomorpholinone
  • Antigens, CD19
  • CCL19 protein, human
  • CCL20 protein, human
  • CCL21 protein, human
  • CCL25 protein, human
  • CCR6 protein, human
  • CD40 Antigens
  • CXCL12 protein, human
  • CXCR5 protein, human
  • Chemokine CCL19
  • Chemokine CCL20
  • Chemokine CCL21
  • Chemokine CXCL12
  • Chemokines
  • Chemokines, CC
  • Chemokines, CXC
  • Ethylenediamines
  • Lipopolysaccharides
  • Macrophage Inflammatory Proteins
  • Morpholines
  • Receptors, CCR6
  • Receptors, CXCR4
  • Receptors, CXCR5
  • Receptors, Chemokine
  • Receptors, Cytokine
  • Interleukin-4
  • RNA